What is the target blood glucose range during the treatment of DKA?

The target blood glucose range during the treatment of diabetic ketoacidosis (DKA) is typically set between 150-200 mg/dL. This range is aimed at safely managing the hyperglycemic state while also addressing the underlying metabolic derangements associated with DKA.

In treating DKA, it is crucial to gradually lower blood glucose levels rather than making abrupt changes that can lead to complications such as cerebral edema. The 150-200 mg/dL range is both effective and safe, allowing for controlled administration of insulin and fluids while monitoring the patient's response. This threshold helps in resolving ketosis and correcting acidosis while maintaining patient safety.

Other options are less appropriate as they either suggest excessively high ranges, which could exacerbate hyperglycemia and delay recovery from DKA, or excessively low ranges, which might compromise patient stability during the treatment phase. The focus should be on a careful, systematic approach to lowering blood glucose within the established targets while ensuring that the patient’s overall condition is being addressed effectively.